Short Interest in ChronoScale Corporation Common Stock (NASDAQ:CHRN) Declines By 49.4%

ChronoScale Corporation Common Stock (NASDAQ:CHRN) was the recipient of a significant decline in short interest in July. As of July 31st, there was short interest totaling 598,565 shares, a decline of 49.4% from the July 15th total of 1,182,882 shares. Based on an average daily trading volume, of 281,263 shares, the short-interest ratio is presently 2.1 days. Approximately 18.0% of the shares of the company are short sold.

ChronoScale Corporation Common Stock Price Performance

Shares of CHRN stock traded up $0.31 during mid-day trading on Friday, reaching $20.93. The company’s stock had a trading volume of 99,789 shares, compared to its average volume of 213,151. The firm’s 50-day moving average is $21.40 and its two-hundred day moving average is $15.22. The company has a market cap of $74.51 million, a P/E ratio of -3.89 and a beta of 1.00. ChronoScale Corporation Common Stock has a 1-year low of $3.01 and a 1-year high of $30.00. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.03 and a current ratio of 1.55.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last posted its earnings results on Tuesday, June 30th. The company reported ($3.89) earnings per share for the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 197.81%. The business had revenue of $18.09 million during the quarter. On average, research analysts predict that ChronoScale Corporation Common Stock will post -0.1 earnings per share for the current year.

Hedge Funds Weigh In On ChronoScale Corporation Common Stock

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Roble Belko & Company Inc boosted its stake in ChronoScale Corporation Common Stock by 104.5% in the 1st quarter. Roble Belko & Company Inc now owns 2,338 shares of the company’s stock valued at $25,000 after buying an additional 1,195 shares in the last quarter. J.Safra Asset Management Corp acquired a new position in ChronoScale Corporation Common Stock during the second quarter worth $48,000. Virtu Financial LLC bought a new position in shares of ChronoScale Corporation Common Stock during the third quarter valued at $57,000. Shay Capital LLC acquired a new stake in shares of ChronoScale Corporation Common Stock in the 3rd quarter valued at $67,000. Finally, Osbon Capital Management LLC acquired a new stake in shares of ChronoScale Corporation Common Stock in the 2nd quarter valued at $81,000. Institutional investors own 6.42% of the company’s stock.

ChronoScale Corporation Common Stock Company Profile

Ekso Bionics Holdings, Inc (NASDAQ:EKSO) is a leading developer of wearable bionic exoskeletons designed to enhance human mobility and strength. Headquartered in Richmond, California, the company was founded in 2005 (originally as Berkeley Bionics) and completed its initial public offering in 2014. Its patented robotic systems support both rehabilitation and industrial applications by providing powered, adjustable assistance for a range of movement tasks.

In the medical sector, Ekso Bionics offers externally worn exoskeletons such as the EksoNR and EksoGT, which assist patients recovering from stroke, spinal cord injury or other neurological conditions.